A Phase I/II Study of CS2009 in Participants With Advanced Solid Tumors
A phase 1/2 trial of Pemetrexed, Carboplatin, Etoposide, Oxaliplatin, Capecitabine and Docetaxel in advanced solid tumours, run by CStone Pharmaceuticals, now recruiting.
Overview
A Phase I/II Study of CS2009 in Participants With Advanced Solid Tumors is a phase 1/2 interventional study registered as NCT06741644 by CStone Pharmaceuticals, with 800 participants planned, started 2025-02-24 and due to reach its primary completion in 2027-01. Interventions recorded: CS2009, Pemetrexed, Carboplatin, Paclitaxel, Etoposide and Nab-paclitaxel.
Similar pages
not linked directly; found by shared links- TrialA Clinical Trial of LBL-024 Combination Drug in Patients With Advanced Solid Tumours[Substudy 01(NSCLC)]
Shares Docetaxel, Pemetrexed, Carboplatin, Metastatic cancer (cancer that has spread) and the tag pipeline.
- TrialA Solid Tumor Study for Long Term Treatment of Cancer Patients Who Participated in Adagrasib Studies
Shares Oxaliplatin, Docetaxel, Pemetrexed, Metastatic cancer (cancer that has spread) and the tag pipeline.
- TrialEvaluation of the Preliminary Efficacy and Safety of DR30206 in Combination With Standard Therapy in Patients With Gastrointestinal Cancer
Shares Oxaliplatin, Capecitabine, Metastatic cancer (cancer that has spread) and the tag pipeline.
- TrialA Phase II Clinical Trial of LBL-024 Combination Drug in Patients With Advanced Solid Tumour[Substudy 04]
Shares Oxaliplatin, Capecitabine, Metastatic cancer (cancer that has spread) and the tag pipeline.
- TrialA Study of ASP388B Given by Itself and With Standard Therapies in Participants With Solid Tumors
Shares Oxaliplatin, Carboplatin, Metastatic cancer (cancer that has spread) and the tag pipeline.
- TrialA Study of Neoadjuvant Chemotherapy Plus Nivolumab Versus Neoadjuvant Chemotherapy Plus Placebo, Followed by Surgical Removal and Adjuvant Treatment With Nivolumab or Placebo for Participants With Surgically Removable Early Stage Non-small Cell Lung Cancer
Shares Docetaxel, Pemetrexed, Carboplatin and the tag pipeline.
- TrialClinical Studies for the Treatment of Advanced Solid Tumors
Shares Oxaliplatin, Capecitabine, Metastatic cancer (cancer that has spread) and the tag pipeline.
- TrialA Trial of SHR-7787 Injection Combined With Other Anti-tumor Drugs in Patients With Malignant Solid Tumors
Shares Etoposide, Carboplatin, Metastatic cancer (cancer that has spread) and the tag pipeline.